The main concern regarding women with positive anti-Ro/SSA antibodies is the risk of giving birth to children with neonatal lupus, which leads not only to cutaneous or hematological manifestations (anemia, thrombocytopenia), but also to consequences such as CHB. The gene discussed is TRIM21; the disease is anemia (phenotype).